Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Maxim Group Initiates Coverage On Helius Medical Tech with Buy Rating, Announces Price Target of $1

Maxim Group analyst Anthony Vendetti initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Buy rating and announces Price Target of $1.
byBenzinga Newsdesk
December 20, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Maxim Group analyst Anthony Vendetti initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Buy rating and announces Price Target of $1.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Don’t Call It A Comeback, But ChatGPT’s Stock Picks Are Bouncing In Benzinga Experiment

By AJ Fabino
September 15, 4:10 PM
We are marching into the 19th week of Benzinga's series, "Is ChatGPT A Better Financial Advisor?" With only seven weeks left in this six-month experiment, every basis point matters as ChatGPT seeks to climb the ranks and narrow the gap with the top portfolios.

ADBE